[ad_1]
Shares of SunPower climbed 9.2% Wednesday, with the maker of solar-energy technology buoyed by strong second-quarter results from solar-panel maker First Solar.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...